AF
RXST icon

Amalgamated Financial’s RxSight RXST Stock Holding History

Amalgamated Financial’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$26K Buy
+2,072
New +$24.9K ﹤0.01% 2666

Other funds holding RXST

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cresset Asset Management Chicago, Illinois $23.1B AUM 27.04% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

Amalgamated Financial's RXST Position: Q1 2022 in Review

Amalgamated Financial opened a new position in RxSight (RXST) in Q1 2022: 2,072 shares worth $26K. The stake represents ﹤0.01% of the portfolio and ranks #2666 among its holdings.

45 funds tracked by Wall St. Rank hold RXST as of Q1 2022.

  • Amalgamated Financial held 2,072 shares of RxSight worth $26K as of Q1 2022.
  • RxSight was a new Amalgamated Financial position in Q1 2022.
  • RxSight made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2666 holding.
  • 45 funds tracked by Wall St. Rank held RxSight as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.